Global X Cannabis ETF (POTX)
| 3.67 Delayed Data As of May 20 |  -0.08 / -2.13%Today’s Change | 3.20 Today|||52-Week Range 16.47 | -36.93% Year-to-Date |
Investment Objective
The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cannabis Index. The fund invests at least 80% of its total assets in the securities of the underlying index and in American Depositary Receipts ("ADRs") and Global Depositary Receipts ("GDRs") based on the securities in the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are active in the cannabis industry (collectively, " Cannabis Companies"), as defined by Solactive AG, the provider of the underlying index ("index provider"). The fund is non-diversified.
Latest POTX News
No recent news for Global X Cannabis ETF.
Performance
| 1 month | -17.86% | 3 years | -- | |
| 3 months | -27.78% | 5 years | -- | |
| 1 year | -69.57% | Since inception | -48.44% |
Data through 05/20/2022
Quote Details
| Previous close | $3.75 |
| Open day’s range | 3.59 – 3.82 |
| Net asset value (NAV) | 3.77 (05/19/2022) |
| Daily volume | 3,511 |
| Average volume (3 months) | 196,673 |
Data as of 4:04pm ET, 05/20/2022
Peer Comparisonvs. Miscellaneous sector ETFs
| POTX | Category | |
|---|---|---|
| Performance 5-yr return | -- | +13.67% |
| Expense Gross exp ratio | 0.50% | -- |
| Risk 5 year sharpe ratio | -- | -- |
| Net assets | $70.4M | -- |
| Average market cap | $529.9M | $11.5B |
| Average P/E | -- | 22.4 |
| Dividend / Share | -- | 0.04% |
Competitors
| No competitors data available. |
Holdings
Top 5 SectorsPortfolio weighting
| Business service | -- |
| Consumer goods | -- |
| Consumer service | -- |
| Energy | -- |
| Financial service | -- |
Top 10 HoldingsPortfolio weighting
| SNDL Sundial Growers Inc | 10.00% |
| -- | 9.61% |
| TLRY Tilray Brands Inc | 8.63% |
| -- | 8.48% |
| -- | 7.46% |
| -- | 7.38% |
| INCR InterCure Ltd | 5.22% |
| AFCG AFC Gamma Inc | 4.65% |
| MYMD MyMD Pharmaceuticals Inc | 4.47% |
| -- | 4.45% |
